Diclofenac Epolamine
CAS No. 119623-66-4
Diclofenac Epolamine ( DHEP | DIEP | diclofenac hydroxyethylpyrrolidine )
产品货号. M27544 CAS No. 119623-66-4
双氯芬酸依波拉明是一种非甾体类抗炎药 (NSAID),具有镇痛和解热作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥324 | 有现货 |
|
10MG | ¥462 | 有现货 |
|
25MG | ¥761 | 有现货 |
|
50MG | ¥1118 | 有现货 |
|
100MG | ¥1604 | 有现货 |
|
200MG | ¥2406 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Diclofenac Epolamine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述双氯芬酸依波拉明是一种非甾体类抗炎药 (NSAID),具有镇痛和解热作用。
-
产品描述Diclofenac Epolamine is a non-steroidal anti-inflammatory agent (NSAID) with analgesic and antipyretic actions.
-
体外实验Flector Patch (Diclofenac epolamine) (1.3% w/w, 24 hours) increases diclofenac partitioning into the skin.Flector Patch (Diclofenac epolamine) (1.3% w/w) loaded by Microemulsion (ME) enhances the transport of drug through skin and sustains to 12 h after removal of ME.
-
体内实验Flector Patch (Diclofenac epolamine) (1.3% w/w, exteral application) displays effective in treating inflammatory conditions. Animal Model:Rat paw edema inflammation model (induced with carrageenan)Dosage:1.3% w/w Administration:Exteral application Result:Inhibited edema and showed anti-inflammatory efficacy at 6 hours after application.
-
同义词DHEP | DIEP | diclofenac hydroxyethylpyrrolidine
-
通路Others
-
靶点Other Targets
-
受体Voltage-gated sodium channel
-
研究领域——
-
适应症——
化学信息
-
CAS Number119623-66-4
-
分子量411.32
-
分子式C20H24Cl2N2O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOCCN1CCCC1.OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ilyin VI, et al. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels. Br J Pharmacol. 2005 Mar;144(6):801-12.
产品手册
关联产品
-
Methyl pentadecanoat...
十五烷酸甲酯是一种天然产物。十五烷酸甲酯是由肉豆蔻酸酯化得到的饱和脂肪酸甲酯。肉豆蔻酸甲酯在 B16F10 黑色素瘤中显示出高黑色素诱导作用。
-
2-Methoxyfuranoguaia...
2-Methoxyfuranoguaia-9-ene-8-one is a natural product for research related to life sciences.
-
Gigantol
Gigantol 是一种新型 Wnt/β-catenin 通路抑制剂。它通过下调乳腺癌细胞中磷酸化的 LRP6 和胞质 β-连环蛋白来抑制 Wnt/β-连环蛋白信号传导。